Du Yi

New Journey Health Technology Group, formerly known as Duyiwei Pharmaceutical, is a leading Chinese healthcare company that operates through two primary segments: medical services and pharmaceutical manufacturing. The company's pharmaceutical division is built on the legacy of the 'Duyiwei' brand, specializing in proprietary Chinese patent medicines derived from Tibetan medicinal plants like Lamiophlomis rotata. Its flagship products, such as Duyiwei capsules and Shenqi Wuweizi tablets, are widely used for pain relief, hemostasis, and treating inflammatory conditions. In addition to its manufacturing capabilities, the group manages an extensive network of over 20 hospitals across China, focusing on specialized care in oncology, cardiovascular diseases, and orthopedics.